You just read:

NCCN Guidelines For Neuroendocrine Tumors Include XERMELO In Combination With Somatostatin Analog Therapy As A Recommended Treatment Option For Patients With Carcinoid Syndrome Diarrhea

News provided by

Lexicon Pharmaceuticals, Inc.

19 Jun, 2017, 07:00 ET